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Abstract
Induced pluripotent stem cells (iPSCs) may serve as an autologous source of replacement neurons in the
injured cochlea, if they can be successfully differentiated and reconnected with residual elements in the
damaged auditory system. Here, we explored the potential of hiPSC-derived neurons to innervate early
postnatal hair cells, using established in vitro assays. We compared two hiPSC lines against a wellcharacterized hESC line. After ten days' coculture in vitro, hiPSC-derived neural processes contacted inner
and outer hair cells in whole cochlear explant cultures. Neural processes from hiPSC-derived neurons also
made contact with hair cells in denervated sensory epithelia explants and expressed synapsin at these
points of contact. Interestingly, hiPSC-derived neurons cocultured with hair cells at an early stage of
differentiation formed synapses with a higher number of hair cells, compared to hiPSC-derived neurons
cocultured at a later stage of differentiation. Notable differences in the innervation potentials of the
hiPSC-derived neurons were also observed and variations existed between the hiPSC lines in their
innervation efficiencies. Collectively, these data illustrate the promise of hiPSCs for auditory neuron
replacement and highlight the need to develop methods to mitigate variabilities observed amongst hiPSC
lines, in order to achieve reliable clinical improvements for patients.
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Induced pluripotent stem cells (iPSCs) may serve as an autologous source of replacement neurons in the injured cochlea, if they
can be successfully differentiated and reconnected with residual elements in the damaged auditory system. Here, we explored the
potential of hiPSC-derived neurons to innervate early postnatal hair cells, using established in vitro assays. We compared two hiPSC
lines against a well-characterized hESC line. After ten days’ coculture in vitro, hiPSC-derived neural processes contacted inner and
outer hair cells in whole cochlear explant cultures. Neural processes from hiPSC-derived neurons also made contact with hair cells
in denervated sensory epithelia explants and expressed synapsin at these points of contact. Interestingly, hiPSC-derived neurons
cocultured with hair cells at an early stage of differentiation formed synapses with a higher number of hair cells, compared to
hiPSC-derived neurons cocultured at a later stage of differentiation. Notable differences in the innervation potentials of the hiPSCderived neurons were also observed and variations existed between the hiPSC lines in their innervation efficiencies. Collectively,
these data illustrate the promise of hiPSCs for auditory neuron replacement and highlight the need to develop methods to mitigate
variabilities observed amongst hiPSC lines, in order to achieve reliable clinical improvements for patients.

1. Introduction
The ANs are responsible for faithfully transmitting acoustic
information from the inner ear to the brain. The cell bodies
of these neurons reside in a bony channel called Rosenthal’s
canal, which is located in the middle (modiolus) of the
cochlea. Each of these cell bodies extends a peripheral process
towards the organ of Corti to innervate the sensory hair cells,
while the central processes project into the auditory nerve
and ultimately synapse with neurons in the cochlear nucleus.
In severe sensorineural hearing loss, the numbers of these
neurons are significantly reduced or lost [1, 2], resulting in
a breakdown of sound transmission to the brain. A variety
of measures have been explored over the last two decades to
restore or replace the damaged ANs following hearing loss,

one being the use of stem cells. In order for stem cells to be
used as a therapy for AN replacement, it is important that the
donor cells are derived from a suitable source and are capable
of innervating the appropriate cells/tissues in the peripheral
and central auditory system [3].
Several studies have explored the capacity for various
human stem cell types to grow towards sensory hair cells
[3, 4] and cochlear nucleus tissues [5, 6] in vitro. These studies
demonstrated that the cocultured stem cell-derived neural
progenitors are capable of innervating developing hair cells
[3, 5] and differentiating into both neuronal and glial lineages
[4]. Importantly, several studies have observed the expression
of synaptic markers including synapsin 1 and GluR2/3 in the
stem cell-derived neural processes at regions adjoining or
adjacent to the hair cells (detected using immunochemistry;
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[3, 4, 7–9]). Additionally, Matsumoto and colleagues [8]
revealed that after coculturing mouse embryonic stem cells
(ESCs) with denervated cochlear explants for one week in
vitro, the ESC-derived neural processes appeared to be highly
vesiculated and in direct contact with the inner hair cell
(IHC) membranes (substantiated by transmission electron
microscopy; [8]). Whilst these data indicate the potential
for stem cell-derived neurons to innervate developing hair
cells, publications describing the innervation of IHCs and/or
outer hair cells (OHCs) by hiPSC-derived neurons are not yet
available.
Several promising in vivo studies also support the use of
stem cells for AN replacement [4, 10]. For instance, following
transplantation of hESC-derived neurons into the cochlea
of deafened animals, hESC-derived neurons extended their
neural processes towards and contacted the base of the hair
cells [4, 10]. Moreover, these stem cell-derived neural fibres
were reported to express GluR2 and NKA𝛼3 at the basal pole
of the IHCs, a marker of afferent nerve terminals [10]. Chen
and colleagues also reported that transplanted hESC-derived
auditory neural progenitors could synapse with their central
(cochlear nucleus) targets in a deafened (auditory neuropathy) experimental model [10]. Importantly, the authors
reported a 46% restoration in auditory function following
stem cell transplantation. Whilst these exciting findings have
very promising clinical implications, the long-term consequences of allotransplantation of hESCs into the cochlea,
including the instigation of an immunogenic response and/or
teratoma formation, remain unresolved. The use of autologous stem cell types for AN replacement [11], including hiPSCs, may minimize the risks associated with immunorejection and thus warrant further investigation.
To our knowledge, there has only been one published
study that has explored the potential for iPSC-derived neurons to make contacts with sensory hair cells in vitro [9].
In this study, the authors’ differentiated mouse induced
pluripotent stem cells (miPSC) toward a neural lineage using
the stromal cell-derived inducing activity method and then
cocultured these neurons with developing cochlear explants.
After seven days of coculture, miPSC-derived neural processes extended toward hair cells in 50% (𝑛 = 6) of the
cochlear explants examined. Of the three cocultures that
reported neurite extension, iPSC-derived neural processes
grew in close proximity to the hair cells. Whilst these data
are encouraging, it is yet to be determined if miPSC-derived
neurons are capable of making direct contact and/or forming
synaptic connections with the sensory hair cells in vitro or in
vivo. Furthermore, for this therapy to be clinically applicable,
it is vital that the donor cells are of human origin. Therefore,
the focus of the current study was to determine whether
hiPSC-derived sensory neurons could innervate the sensory
hair cells in vitro, whether there were differences in their
ability to do so (comparing two hiPSC lines to a control hESC
line), and the efficacy with which any innervation occurred.
The present study employed a well-characterized assay for
producing high numbers of AN-like sensory neurons from
human pluripotent stem cell lines, as recently described [12].
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2. Materials and Methods
2.1. Cell Lines. The iPS1 and iPS2 ([13]; WiCell) and the
hESC line, H9 ([14]; WA-09; WiCell), were used in this
study. Passage numbers ranged from 71 to 94 (iPS1), 33 to
48 (iPS2), and 85 to 140 (H9). The tissue culture procedures
were performed using aseptic techniques in class II biological
safety cabinets, as recently described [12]. Stem cells were
maintained at 37∘ C, 5% CO2 , and differentiated at 37∘ C, 10%
CO2 in humidified incubators.
2.2. Neural Differentiation. The stem cells were maintained
and differentiated using procedures previously described
[12]. Briefly, the undifferentiated cells were maintained
in Knockout Serum Replacement media (1 : 1 DMEM/F12
with Glutamax, 20% Knockout Serum Replacement, 10 mM
Nonessential Amino Acids, and 55 mM 𝛽-Mercaptoethanol;
all purchased from Life Technologies) supplemented with
10 𝜇g/mL of basic fibroblast growth factor (bFGF; Peprotech)
on a layer of mitotically inactivated human feeders (CCD1079Sk human foreskin fibroblast cell line; ATCC). The cells
were routinely passaged each week.
The stem cells were differentiated towards a neural lineage by treating cells with Noggin media, which contained
neurobasal media (NBM; neurobasal A with 1% N2, 2% B27,
2 mM L-Glutamine, and 0.5% Penicillin/Streptomycin; all
purchased from Life Technologies), 500 ng/mL of Recombinant Noggin (R&D Systems), and 4 ng/mL of bFGF for two
weeks. To promote neurosphere formation, the cell colonies
were mechanically dissected into small sections and transferred into 96-well low attachment plate (Sigma-Aldrich)
containing NBM supplemented with epidermal growth factor
(EGF; Peprotech) and bFGF (20 ng/mL each). After four days
(18 DIV), the neurospheres were plated onto gelatinized organ
culture dishes that contained a layer of inactivated human
feeders (CCD-1079Sk; ATCC) and NBM supplemented with
EGF and bFGF (20 ng/mL each), followed by treatment with
the Rho-kinase inhibitor Y27632 (25 𝜇M, Sigma-Aldrich) at
19 and 20 DIV [12]. The neurospheres were cocultured with
the early postnatal cochlear explants at 21 and 28 DIV.
2.3. Animals and Experimental Groups. Time-mated pregnant Hooded-Wistar rats were obtained from the Biological
Research Centre at the University of Adelaide, Australia.
Two coculture assays were employed. The first assay involved
coculturing stem cell-derived neurons with cochlear explants
(hair cells and peripheral AN fibres) obtained from postnatal
day 3/4 (P3/4) rat pups. Explant only controls were set up
identically for each experiment. The second coculture assay
involved culturing the stem cell-derived neurons with denervated cochlear explants (hair cells only [3, 15]) dissected from
P2/3 rat pups. Each experiment was repeated in triplicate
using animals from three different litters.
2.4. Cochlear Explant Dissections and Coculture Experiments.
The cochlear explants were dissected from early postnatal rats
using methods previously described [16]. For synaptogenesis
assays, the hair cells were dissected from the peripheral
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Figure 1: Timeline for coculture experiments. The stem cell lines were differentiated towards a neuronal lineage for either 21 or 28 days in
vitro (DIV). For the cochlear explant cocultures, 21 DIV neurospheres were cocultured with cochlear explants for up to 10 days (red). For the
synapse forming assay experiments, 21 (red) and 28 (blue) DIV neurospheres were cocultured with hair cells for 10 days in each case. The
cocultures were treated with NBM, BDNF, and NT-3. DIV: days in vitro; NBM: neurobasal media; EGF: epidermal growth factor; bFGF: basic
fibroblast growth factor; HFF: human foreskin fibroblasts; CE: cochlear explant; HC: hair cell; NS: neurosphere; and Y27: small molecule
Y27632.

processes of ANs, thereby denervating the cochlear explant,
using techniques previously described [3, 17]. The cochlear
explants and denervated cochlear explants (hair cells only)
were grown on 0.4 𝜇m organotypic membranes (Millipore) in
coculture media containing NBM supplemented with brainderived neurotrophic factor and neurotrophin-3 (each added
to give a final concentration of 10 ng/mL; Chemicon).
Whole cochlear explants were cocultured with either 21day-old hiPSC or hESC neurospheres (Figure 1). Denervated
cochlear explants were cocultured with either 21 DIV or
28 DIV hiPSC or hESC neurospheres. The cocultures were
incubated at 37∘ C, 10% CO2 for 1 DIV (explant only control),
or 10 DIV (stem cell + explant/denervated explant cocultures). The coculture media were replenished every 2 DIV
(100 𝜇L/membrane).
2.5. Immunochemistry. The cocultures and explants were
fixed by immersing in 4% paraformaldehyde for approximately 10 minutes, followed by careful rinsing (three times
for five minutes) with phosphate buffered saline (PBS).
The explant only controls were fixed after 1 DIV, whereas
the experimental cocultures were fixed after 10 DIV. All
explants were immunostained with a relevant combination
of the following primary antibodies: rabbit anti-Myosin VIIa
(1 : 100; Sapphire Bioscience; 25-6790), mouse anti-human
Neurofilament (IgG1) (hNFM; 1 : 1500; Sapphire Bioscience;
MAB5186), chicken anti-Neurofilament H (IgG) (1 : 1000;
Millipore; AB5735), goat anti-Prestin (1 : 400; ThermoFisher
Scientific; sc-22692), mouse anti-Peripherin (IgG1) (1 : 1000;
Millipore; MAB1527), rabbit anti-synapsin 1 (1 : 200; Life
Technologies; A6442), and goat anti-parvalbumin (1 : 3000;
Swant; PVG-214).

For the cochlear explant cocultures, the primary antibodies were diluted in primary blocking solution (0.1% TritonX (Sigma-Aldrich), containing 2% of the relevant serum,
either goat (Abacus ALS) or donkey (Millipore) diluted
in PBS) and then added to the membranes at 200 𝜇L per
well before being stored overnight at 4∘ C in a humidified
container. The following day, the cells were rinsed thrice for
five minutes in primary blocking solution. The Alexa Fluorconjugated secondary antibodies (all purchased from Life
Technologies) diluted in secondary blocking solution (0.1%
Tween (Sigma-Aldrich), 2% goat or donkey serum in PBS, as
described above) were added to the membranes at a volume
of 200 𝜇L per well. The slides were then transferred into a foil
covered, humidified container and left for 2 hours at room
temperature in the dark with gentle rotation. After 2 hours,
the cells were washed thrice for five minutes in PBS, mounted
with ProLong-Gold antifade reagent containing the nuclear
stain 4 , 6-diamidino-2-phenylindole (DAPI; Invitrogen),
and sealed with varnish the next day.
For the denervated cochlear explants, the cocultures were
blocked in primary blocking solution (0.1% Triton-X, 10%
goat serum in PBS) for 1 hour with gentle rotation. A higher
percentage of serum was used to minimize background staining for the synapse assay cocultures. The primary antibodies
were diluted in primary blocking solution at 200 𝜇L per well,
added to the membranes, and stored overnight at 4∘ C in a
humidified container. The next day the cells were rinsed in
primary blocking solution (8 × 10 minutes). Alexa Fluorconjugated secondary antibodies were diluted in the secondary blocking solution (0.1% Tween, 10% goat, or donkey
serum in PBS) and added to the membranes at 200 𝜇L per
well. The secondary antibodies were spun before and after
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dilution in secondary blocking solution. The slides were
transferred into a foil covered, humidified container and
left for 1.5 hours at room temperature in the dark with
gentle rotation. After 1.5 hours, the membranes were washed
thrice for five minutes in PBS, mounted with ProLong-Gold
antifade reagent containing DAPI, and sealed with varnish
the next day.
2.6. Microscopy. Stained explants were visualized using confocal microscopy and images were taken using an LSM
510 META confocal scanning laser system with a Zeiss
AxioImagerZ1 microscope. Optical slice thickness was set to
8.49 𝜇m. Zen digital imaging software (Carl Zeiss) was used
to process and analyze the images.
2.7. Quantification. For the cochlear explant cocultures, four
regions of the explant were selected at random and quantified
under 40x magnification. The number of stem cell-derived
neural processes making contact with the hair cells was
counted relative to the total number of hair cells present in
the selected region. Additionally, we noted the total number
of explants in which stem cell-derived hair cell innervation
was observed and compared this to the total number of
explants in the study. We used this later number in order to be
able to directly compare our results with the recent relevant
publication using mouse iPSC-derived neurons [9].
For the synaptogenesis assays, the total number of hair
cells in the denervated cochlear explant was counted under
63x magnification. The number of hair cells making contact
with synapsin 1 positive stem cell-derived neural processes
was counted [17], relative to the total number of hair cells.
Statistical analysis of the coculture data was performed
using GraphPad Prism (Version 6). Where data was normally distributed (Anderson-Darling test), a Student’s 𝑡-test
was used. For nonparametric data, a Kruskal-Wallis oneway analysis of variance (ANOVA) was used to determine
statistical significance between the groups compared. Values
of 𝑝 < 0.05 were considered statistically significant, with
ranges in significance from ∗ 𝑝 ≤ 0.05, ∗∗ 𝑝 ≤ 0.01, and
∗∗∗ 𝑝
≤ 0.001. Data are presented as the mean ± standard
error of mean (SEM).
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the rows of hair cells in the cochlear explant. The neural
processes grew in fasciculating bundles along the basolateral
surface of the hair cells in several of the stem cell cocultures,
similar to the pattern of normal OHC innervation in the
mammalian cochlea (Figures 2(d) and 2(e)). Under higher
magnification, both the hiPSC- and hESC-derived neurons
were observed to make direct contact with the sensory hair
cells in the explant. However, the hiPSC-derived neural
processes made contact with fewer hair cells compared to the
hESCs (iPS1 16.9 + 4.8%, 𝑛 = 16, ∗ 𝑝 < 0.05; iPS2 16.4 + 3.6%,
𝑛 = 17, ∗ 𝑝 < 0.05; H9 39.5 + 12.1%, 𝑛 = 12; Figure 2(f)).
Overall, there was no significant difference in the average
number of hair cells that the iPS1 and iPS2 cell lines were
contacting throughout the cocultures examined (𝑝 = 0.38;
Figure 2(f)). However, when the data was analyzed in terms
of the number of explants in which hair cells were contacted
by stem cell-derived neurons, the iPS2 cell line demonstrated
a greater consistency of innervation in comparison to the iPS1
line, (iPS1 𝑛 = 16, 62.5% of explants innervated; iPS2 𝑛 = 17,
94.2% of explants innervated; ∗ 𝑝 < 0.05).

3. Results

3.2. Human iPSC-Derived Neural Progenitors Grew toward
Both the Inner and Outer Hair Cells in Whole Cochlear
Explant Cocultures. To investigate whether the stem cellderived neural processes were contacting the IHCs, OHCs, or
both, a Prestin antibody was used to distinguish the OHCs in
the explant cocultures (Figure 3(a)). All hair cells are Myosin
VIIa positive, but only the outer hair cells express the motor
protein Prestin. As expected, after 1 DIV there were a significantly higher number of OHCs in the explants compared to
the IHCs (Figure 3(e); ∗∗∗ 𝑝 < 0.001). At 10 DIV, there was a
significant decrease in the overall numbers of surviving IHCs
and OHCs, demonstrating a decline in the relative proportion
of IHC and OHC normally observed within the cochlea. In
cocultures, no significant differences were observed in the
number of IHCs that the stem cell-derived neural processes
contacted, when compared to the numbers of OHCs that
these cells contacted (Figures 3(b)–3(d) and 3(e); iPS1 IHCs
= 12.3 + 5.8%, OHCs = 9.4 + 5.9%, 𝑛 = 6, 𝑝 = 0.79; iPS2 IHCs
= 18.5 + 12.2%, OHCs = 23.2 + 12.2%, 𝑛 = 7, 𝑝 = 0.73; and H9
IHCs = 27.1 + 12.4%, OHCs = 32.9 + 5.8%, 𝑛 = 6, 𝑝 = 0.68).
Notably, the iPS1-derived neurons showed significantly less
OHCs innervation in comparison to the H9-derived neurons
(∗ 𝑝 < 0.05; Figure 3(e)).

3.1. Human iPSC-Derived Neural Progenitors Contacted Sensory Hair Cells in Whole Mammalian Cochlear Explant
Cocultures. In order to investigate whether hiPSC-derived
neurons could contact their peripheral targets (the sensory
hair cells), 21 DIV neural progenitors derived from two
hiPSC lines (iPS1 and iPS2) and one hESC (H9; control)
line were cocultured with P3/4 whole cochlear explants
(Figure 2(a)). After 10 DIV, the hiPSC- and hESC-derived
neurons preferentially extended their processes toward and
into the explant. Compared to the organized innervation
pattern observed in the directly isolated cochlear explant
(Figure 2(b)), the stem cell-derived neural processes grew in
a disorganized manner (Figures 2(c)–2(e)). Additionally, the
neural processes were observed to extend towards and along

3.3. Human iPSC-Derived Neural Progenitors Made Synaptic
Connections with Hair Cells in Denervated Cochlear Explant
Cocultures. As the innervation of iPS2-derived neurons was
more efficient when considered in terms of both the overall
percentage of explants innervated (94.2%, ∗ 𝑝 < 0.05) and
fewer numbers of OHCs innervated by the iPS1-derived
neurons after 10 DIV (∗ 𝑝 < 0.05; Figure 3(e)), the synaptic capacity of the iPS2- and hESC-derived neurons was
compared next. We first examined the denervated cochlear
explants at 1 and 10 DIV (Figures 4(a)–4(d), resp.). Distal AN
processes were absent in the denervated cochlear explants
after 1 DIV, but an accumulation of residual NFM within
hair cell somata (Figure 4(a)) and synapsin 1 positive puncta

Stem Cells International

5
MyoVIIa

NFM

Human NFM

Merged

Merged1

(a)
EX + NS

iPS1

EX
NS

EX only: 1 DIV

iPS2

(c)

H9

(d)

(b)

(e)

60

Hair cells that stem cell-derived neurons
contacted within whole cochlear explant cultures (%)
∗

Hair cells (%)

∗

40
NS
20

0
iPS1

iPS2
Cell lines

H9

(f)

Figure 2: Coculture of cochlear explants and hESC- and hiPSC-derived neural progenitors. (a) The light microscope image depicts the
cochlear explant cocultured with a stem cell-derived neurosphere (NS). (b) The explant only control obtained from P3 mice shows the normal
innervation pattern of ANs after 1 DIV. (c–e) In cocultures, growth of hESC- and hiPSC-derived neural processes towards and along the rows
of the hair cells was observed. Myosin VIIa (green) labels the hair cells, Neurofilament (NFM; grey) labels the endogenous neural processes,
and human NFM (hNFM; red) labels the stem cell-derived neural processes. The merged1 images represent higher magnification images of
the boxed inserts and depict the contacts made between the stem cell-derived neural processes and hair cells: for example, three points of
contact are shown in (c) merged1 . Scale bar = 50 𝜇m, relevant for all the images. (f) The hiPSC-derived neural processes made contact with
fewer hair cells compared to the hESCs (iPS1 𝑛 = 16, 𝑝 < 0.05; iPS2 𝑛 = 17, 𝑝 < 0.05; H9 𝑛 = 12). There was no significant difference in the
number of hair cells making contact with the iPS1 and iPS2 cell lines (𝑝 = 0.38). A Kruskal-Wallis one-way ANOVA was utilized to determine
statistical significance between the groups compared. Data are presented as the mean ± SEM. Values of ∗ 𝑝 < 0.05 were considered statistically
significant. NS: not significant.

(Figure 4(b)) was observed at this time point. Conversely,
after 10 DIV, there were reduced NFM accumulations within
the hair cell somata (Figure 4(c)) and synaptic puncta were
not detected (Figure 4(d)). Following the coculture of stem
cell-derived neurospheres with denervated cochlear explants
(Figure 4(e)), neural processes projecting towards isolated
sensory hair cells were observed (Figures 4(f)–4(i)). The
neural processes of 21 DIV neurospheres were found to

express high levels of synapsin 1, and synapsin 1 positive
puncta were observed to colocalize with the parvalbuminpositive sensory hair cells in the denervated explant (Figures
4(f) and 4(g)). Moreover, the synaptic connections between
the hair cells and hiPSC-derived neurons were observed to
occur in an en passant manner: that is, single stem cellderived neurites made multiple synaptic connections with
multiple hair cells. Similar observations were reported for
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Figure 3: Innervation of inner hair cells versus outer hair cells by stem cell-derived neurons. (a) The specific labeling of Prestin (grey) to
the OHCs is depicted in the explant only control. (b–d) The hiPSC- and hESC-derived neural processes made contact with both the IHCs
and the OHCs. The merged1 images represent higher magnification images of the boxed inserts and depict the contacts made between the
stem cell-derived neural processes and hair cells. Scale bar = 50 𝜇m, relevant for all the images. (e) Total numbers of hair cells (inner and
outer) were quantified in each group using antibodies against MyoVIIa (all hair cells) and Prestin (outer hair cells only). Data was compared
to controls grown for one day in vitro. There was a significantly higher number of OHCs compared to IHCs in the explant only controls
after 1 DIV (𝑝 < 0.001). At 10 DIV, there was a decline in the number of IHCs and OHCs present in the explants. There were no significant
differences in the number of OHCs that the stem cell-derived neural processes contacted, when compared to the numbers of IHCs these cells
contacted (iPS1 𝑛 = 6, 𝑝 = 0.79; iPS2: 𝑛 = 7, 𝑝 = 0.73; and H9 𝑛 = 6, 𝑝 = 0.68). The iPS1-derived neurons made contact with significantly
fewer OHCs compared to the hESC-derived neurons (𝑝 < 0.05). A Kruskal-Wallis one-way ANOVA was utilized to determine statistical
significance between the groups compared. Values of ∗ 𝑝 < 0.05 were considered statistically significant and data presented as the mean ±
SEM. OHCs: outer hair cells; IHCs: inner hair cells; DIV: days in vitro. The asterisks ∗ highlight the IHCs present in the cultures.
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Figure 4: The synaptic potential of 21- and 28-day-old hiPSC- and hESC-derived neurons. (a-b) In the denervated cochlear explant controls
at 1 DIV, some accumulation of residual NFM within hair cell somata and a few synaptic puncta were observed. (c-d) After 10 DIV, there
appeared to be fewer hair cells with NFM accumulation and synapsin 1 was undetectable. (e) Light microscope image of denervated cochlear
explant cocultured with stem cell-derived neurosphere. (f and g) The hiPSC and hESC neurospheres cocultured at 21 DIV extended their
neural processes towards hair cells in the denervated explants. Punctate-like synapsin 1 expression was observed along the neural processes
of both the hiPSC- and hESC-derived neurites making contact with hair cells. (h and i) The hiPSC and hESC neurospheres cocultured at 28
DIV projected fewer neural processes towards hair cells in the denervated explants. Synapsin 1 was rarely observed along the neural processes
of both the hiPSC- and hESC-derived neurites making contact with hair cells. The merged1 images represent higher magnification images of
the boxed inserts and depict the punctate-like synaptic contacts made between the stem cell-derived neural processes and hair cells. Scale bar
= 20 𝜇m (applicable for all images). (j) The 21-day-old hiPSC- and hESC-derived neurons made contact with a significantly higher number of
hair cells, compared to the 28-day-old neurons (H9: 𝑝 < 0.05). Furthermore, the 21-day-old hESC neurons made contact with a significantly
higher number of hair cells (𝑝 < 0.05). A Student’s 𝑡-test was used to determine statistical significance. Values of ∗ 𝑝 < 0.05 were considered
statistically significant. Data are presented as the mean ± SEM.
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hESC-derived neurons (Figure 4(g); [3]). The microisolate
assay utilized in the current publication results in disorganized hair cell growth and some hair cell senescence after
two weeks in vitro [3, 17]. This is due primarily to fibroblasts
and supporting cells in the culture, which divide after explant
isolation and disrupt the normal hair cell arrangement during
their proliferation. As a result of the microdissection of the
organ of Corti from the explant, the hair cells often do not
retain their arrangement in rows due to lack of ultrastructure
normally provided in whole tissue.
3.4. Innervation of Hair Cells in Denervated Cochlear Explants
Was Significantly Greater Using “Early Stage” Compared to
“Late Stage” Neurospheres. We next quantified the differences
observed in the synapse forming capacity of the iPS2- and
H9-derived neurons when cocultured at either an early stage
of differentiation (21 DIV) or a later stage of differentiation
(28 DIV) in denervated cochlear explants. The 21 DIV
cocultures contained greater numbers of stem cell-derived
processes which contained synapsin 1 at points of contact
with the sensory hair cells, when compared to the cocultures
examined at 28 DIV (Figures 4(f)–4(i)). More specifically,
the neurons derived from 21 DIV H9 neurospheres made
significantly more synaptic connections with hair cells, compared to those derived from 28 DIV neurospheres (H9 21
DIV (31.1 + 9.1%) and 28 DIV (16.7 + 12.5%): 𝑛 = 8; ∗ 𝑝 <
0.05; Figure 4(j)). In addition, the H9-derived neurons from
21 DIV neurospheres also innervated a significantly greater
number of hair cells, compared to the iPS2-derived neurons
from 28 DIV neurospheres (iPS2 28 DIV (9.3 + 4.6%): 𝑛 = 8;
𝑝 < 0.05; Figure 4(j)).

4. Discussion
The intricate wiring of ANs and the refined tonotopic organization of the inner ear facilitate the transmission of accurate
sound information from the external environment to the
brain. Prompting stem cells to differentiate and replicate the
refined innervation pattern and functionalities of primary
ANs is a significant challenge. Several previous studies have
reported the potential for hESC to establish new synapses
with hair cells in the auditory periphery [3, 4, 10]; however,
this remains to be demonstrated for hiPSCs. Here, we report
that hiPSC-derived neurons can make direct contact with
and form synapses on developing sensory hair cells in vitro.
However, the hiPSC-derived neurons had a lower innervation
capacity compared to hESC-derived neurons. These observations are consistent with our recent investigations which
examined the variable differentiation potentials of the cell
lines described herein [12].
4.1. Establishment of Contacts between the hiPSC-Derived
Neurites and Hair Cells in Cochlear Explant Cocultures.
In cochlear explant cultures, hiPSC-derived neurons were
observed to extend their neural processes towards the sensory
epithelium and make direct contact with both IHCs and
OHCs in vitro, an important first step in the reestablishment
of synaptic input (Figure 3). However, compared to the

Stem Cells International
orderly innervation pattern of adult ANs, the hiPSC-derived
neurites appeared to grow towards the sensory epithelium
in a disorganized manner, resembling the pattern of innervation of developing ANs (Figures 2(c)–2(e); [18–20]). This
is supported by observations during the very early stages
of mouse development (E18-P0), where neurites from the
auditory neurons exhibit an immature and highly branched
morphology whereby Type I and Type II ANs innervate both
IHCs and OHCs in vivo [18–20]. As development progresses,
these neurons undergo significant synaptic pruning and neural refinement, such that Type I neurons ultimately contact
only IHCs and Type II neurons only contact OHCs [18].
4.2. hiPSC-Derived Neurons Form Immature Synaptic Terminals on Sensory Hair Cells in Denervated Cochlear Explants.
It has previously been observed that the afferent dendrites
of early postnatal ANs isolated from the sensory epithelium
express synaptic markers (synapsin 1 and synaptophysin) as
they regenerate their connections with hair cells in vitro
[8, 21, 22]. Various stem cell-derived neurites have also
been found to express synapsin 1 at regions adjacent to
hair cells in coculture models [3, 4, 7, 8]. Therefore, the
expression of synapsin 1 is considered to be a preliminary
indicator of the capacity for stem cell-derived neurons/ANs
to regenerate or form potentially functional synapses with
hair cells [23]. In the present study, extensive punctate-like
synapsin 1 expression was observed along hiPSC-derived
neural processes making contact with hair cells in denervated explant cultures (Figure 4(f)). Furthermore, stem cellderived synaptic puncta were observed to colocalize at the
basolateral surface of hair cells, indicating the capacity for
hiPSC-derived neurons to form synapses with sensory hair
cells in vitro (Figure 4(f)).
We recently reported that hiPSC-derived neurons had
higher levels of sensory neural marker expression at the later
time points of differentiation (28–35 DIV; [12]). We therefore
suspected that stem cell-derived neurons from these later
stages of differentiation would have different potentials to
innervate hair cells compared to the same neurons derived
from earlier stages of differentiation. We found that hiPSCand hESC-derived neurons cocultured at an earlier stage
of differentiation (21 DIV) formed synapses with a higher
number of hair cells, when compared to the more differentiated stem cell-derived neurons (28 DIV). These findings
emphasize the importance of the stage of differentiation
on the functional integration capacity of stem cell-derived
neurons and support the rationale that neural progenitors
may have better functional outcomes in vivo, compared to
more differentiated neurons [24]. This hypothesis is further
supported by recent in vivo studies reporting that partial
hearing function recovery can be achieved following the
transplantation of early stage hESC-derived otic neural progenitors into deafened gerbil cochleae [10].
4.3. Variability Amongst Stem Cell Lines. Whilst hiPSCderived neurons were capable of directly contacting the
sensory hair cells in vitro, they were also observed to make
contact with fewer hair cells compared to the hESC-derived
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neurons. Moreover, there was no significant difference in the
number of hair cells that the iPS1- and iPS2-derived neurons
made direct contact with in vitro, suggesting comparable
innervation efficiencies. Interestingly, however, if the data
were quantified based upon the number of cultures in
which innervation was observed, inconsistencies between the
iPSC lines examined were apparent. Specifically, the iPS1derived neurons had a lower number of cultures with hair
cell innervation, compared to the iPS2- and hESC-derived
neurons (𝑝 < 0.05; Figure 2). We (and others) have previously
reported that hiPSCs have a more variable differentiation
potential compared to hESCs [12, 25, 26]. Consistent with
these findings, the data presented here indicate that differences exist among human pluripotent stem cell-derived
neurons, particularly hiPSC-derived neurons in their innervation potentials in vitro. However, it needs to be noted
here that differences may be present among cell lines in
their optimal differentiation protocol (e.g., the exact timing
of a particular treatment). As such, future studies assessing
multiple cell lines using optimized differentiation protocols
will be required to assess cell line capacity. On the other hand,
it is possible that the variabilities observed could be due to
the presence of genetic and epigenetic abnormalities recently
detected in hiPSC lines derived from viral integration reprogramming methods [23]. Nevertheless, the findings of the
current study highlight a potential concern associated with
the use of human pluripotent stem cell lines for stem cell
transplants.
In terms of cell transplantation therapies, the presence
of variability amongst cell lines could have several consequences. For instance, there could be differences in the
numbers of ANs generated from each patient and variabilities
in their integration capacities, which could consequently lead
to inconsistencies in the functional outcomes patients achieve
with the therapy. In further support of this idea, Chen and
colleagues have reported varying degrees of auditory function
recovery following the transplantation of hESC-derived neurons into gerbil cochleae [10], which may be due to underlying
variability in cell differentiation. These findings reiterate the
necessity to mitigate potential inconsistencies in functional
outcomes between patients, prior to the clinical translation
of stem cell therapies. The use of hiPSC lines generated using
nonviral integration methods could potentially abate some
of these variabilities and this is worthy of investigation prior
to the transplantation of hiPSC-derived neurons into the
cochlea. The described in vitro cocultures provide a proofof-concept model from which to test the capacity of different
stem cell lines at various stages of differentiation prior to their
in vivo delivery.
In addition to cell transplantation therapies, the capacity
to successfully differentiate hiPSCs towards functional ANs
could facilitate the development of patient-specific cell lines
to model AN degeneration “in a dish.” More specifically,
the derivation of hiPSC-derived ANs from patients with
genetic forms of SNHL, including Usher’s syndrome, Branchiootorenal syndrome, or Waardenburg syndrome (to name
a few), will enable us to obtain a deeper understanding of
the mechanisms underlying these conditions. Furthermore, it
will permit the use of the latest gene editing technologies such
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as clustered regularly interspaced short palindromic repeat(CRISPR-) associated endonucleases [24, 27, 28] to correct
genetic abnormalities in these disease-specific cell lines and
also provide a platform for large-scale drug screening to
potentially suppress AN degeneration [29]. The benefits
of modeling diseases using hiPSCs are clearly numerous;
therefore, this study provides useful insight into the potential
of hiPSCs to recapitulate the functionality of ANs.
4.4. Summary. In conclusion, the present study demonstrated that hiPSC-derived neurons could make direct contact with and form presynaptic connections on developing
hair cells in vitro. Furthermore, it was observed that neural
progenitors derived from pluripotent stem cells cocultured at
an earlier stage of differentiation have a higher innervation
potential compared to the neural progenitors cocultured at a
later stage. These promising findings have directly informed
our hiPSC transplantation studies in the deaf cochlea and
serve as a foundation from which to further investigate the
use of induced pluripotent stem cells for auditory neural
replacement.
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